3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Anemia
2
Uterine Cervical Neoplasms
1
Radiation Injuries
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Erectile Dysfunction
1
Drug-Related Side Effects and Adverse Reactions
1
Bronchiolitis Obliterans Syndrome
1
Interventions
Sildenafil Citrate
2
udenafil
1
methyl 3-mercaptopropionimidate
1
bicalutamide
1
alpha-Tocopherol
1
Vitamin E
1
Tamoxifen
1
Tadalafil
1
Tacrolimus
1
Restraint, Physical
1
Psychiatric Rehabilitation
1
Preservation, Biological
1
Pentoxifylline
1
Menogaril
1
Long-Term Synaptic Depression
1
Intraoperative Neurophysiological Monitoring
1
GPI 1485
1
Exercise
1
Erythropoietin
1
Early Intervention, Educational
1
Dutasteride
1
Cell- and Tissue-Based Therapy
1
Atorvastatin
1
Arginine
1
ArginMax
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Erectile Dysfunction
×
Erythropoietin
×
Clear all
NCT00737893
2021-04-08
ERECT
Johns Hopkins University
Phase 2
Completed
56 enrolled
27 charts